SilverOak Wealth Management’s AbbVie ABBV Stock Holding History

SilverOak Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$321K	Hold	1,274	–	–	0.04%	101
2026 Q1	$277K	Sell	1,274 -3	-0.2%	-$665	0.04%	102
2025 Q4	$292K	Hold	1,277	–	–	0.05%	96
2025 Q3	$296K	Buy	1,277 +116	+10%	+$23.6K	0.05%	93
2025 Q2	$216K	Buy	1,161 +87	+8%	+$16.2K	0.04%	108
2025 Q1	$225K	Buy	+1,074	New	+$209K	0.05%	86
2024 Q4	–	Sell	-1,064	Closed	-$210K	–	100
2024 Q3	$210K	Buy	+1,064	New	+$199K	0.05%	93

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SilverOak Wealth Management's ABBV Position: Q2 2026 in Review

SilverOak Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,274 shares worth $321K. The position accounts for 0.04% of the portfolio, ranked #101.

SilverOak Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

SilverOak Wealth Management held 1,274 shares of AbbVie worth $321K as of Q2 2026.
SilverOak Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.04% of SilverOak Wealth Management's portfolio in Q2 2026, its #101 holding.
SilverOak Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SilverOak Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.